Laser vs Electrohydraulic Lithotripsy for Difficult CBD Stones
Efficacy and Safety of Laser Versus Electrohydraulic Lithotripsy for Difficult Biliary Stones: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
2
Brief Summary
Common bile duct (CBD) stones are a frequent condition that can lead to severe complications if not treated. The standard approach involves endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and stone extraction using balloons or baskets. However, approximately 10-15% of cases involve "difficult CBD stones" that cannot be removed using conventional methods. According to the European Society of Gastrointestinal Endoscopy (ESGE), difficult CBD stones are characterized by large size (≥15 mm), impaction, multiple stones, difficult locations (e.g., intrahepatic or cystic ducts), or altered anatomy due to previous surgeries. These cases require advanced techniques such as single-operator cholangioscopy (SOC) using the SpyGlass DS system, which allows direct stone visualization and lithotripsy-assisted fragmentation. Two primary lithotripsy methods are available: Electrohydraulic Lithotripsy (EHL): Uses shock waves from electrical energy to break stones. Laser Lithotripsy (LL): Uses laser energy to fragment stones through a water-mediated medium. While both techniques are effective, studies suggest LL has a higher first-attempt stone clearance rate (82-100%) compared to EHL (70.9-75%). However, EHL is more cost-effective and widely available, whereas LL offers greater precision but at a higher cost. Currently, no randomized controlled trial (RCT) directly compares their efficacy, procedural time, complication rates, or operator satisfaction. This study aims to fill that gap by conducting a randomized trial comparing EHL and LL in the treatment of difficult CBD stones. The primary outcome is the success rate of complete stone clearance in the first session, while secondary outcomes include procedural duration, post-procedural complications, and operator satisfaction. The findings will provide critical evidence for optimizing endoscopic stone management, improving patient outcomes, and guiding healthcare resource allocation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 22, 2025
May 1, 2025
1.8 years
February 26, 2025
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effectiveness of Electrohydraulic Lithotripsy (EHL) and Laser Lithotripsy (LL)
Comparison of the effectiveness of Electrohydraulic Lithotripsy (EHL) and Laser Lithotripsy (LL) by examining the success rate of complete stone removal on the first procedure.
During the procedure
Secondary Outcomes (5)
Procedure time
Periprocedural (Total procedure time usually 1-2 hours)
Number of catheters used
Periprocedural
Physician satisfaction
Periprocedural
Procedure-related adverse events
up to 2 weeks after the procedure
Length of hospital stay
through after procedure average 1-2 weeks
Study Arms (2)
Laser Lithotripsy
EXPERIMENTALElectrohydraulic Lithotripsy
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Aged \>18 years
- Difficult CBD stone
- Large CBD stone (stone \> 1.5 cm) or Stone impaction or CBD stones that were not completely removed using conventional techniques.
You may not qualify if:
- Pregnancy
- Unstable vital signs
- Severe comorbidities
- Uncorrected coagulopathy
- Surgically altered anatomy
- Unable to complete informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mahidol Universitylead
- Siriraj Hospitalcollaborator
Study Sites (2)
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, Bangkok, 10120, Thailand
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, Bangkok, 10ึ700, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Varayu Prachayakul, MD
Mahidol University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 26, 2025
First Posted
June 22, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Other researchers can contact us anytime.
- Access Criteria
- We will provide our protocol and/or data upon request.
We are willing to provide our data to researchers who require it. For example, those who want to do systematic review and meta-analysis.